A randomized placebo-controlled phase III study of docetaxel/carboplatin with celecoxib in patients with advanced non-small cell lung cancer (NSCLC): The NVALT-4 study

Reviewer: Geoffrey Geiger MD
Abramson Cancer Center of the University of Pennsylvania
Ultima Vez Modificado: 1 de junio del 2009

Translation for this article does not exist


7 Tips for Giving Smart on #givingtuesday
by Christina Bach, MSW, LCSW, OSW-C
November 25, 2015